Today’s guest is Dr. Joseph Sparano, Professor of Medicine & Obstetrics, Gynecology, and Women’s Health, Albert Einstein College of Medicine.
Chemotherapy has been a gold standard for treatment of breast cancer and often over-treats women who may not need this aggressive treatment to treat their breast cancer. Dr. Sparano serves as the study chair for the TAILORx clinical trial sponsored by National Cancer Institute, the first clinical trial integrating a mulitparameter gene expression assay in clinical decision making for adjuvant therapy with early stage ER-positive, HER2 negative breast cancer. The results will eliminate the use of chemotherapy for thousands of women.
“This is really now a third tool that we can use to guide the use of chemotherapy, not in all patients, not in the 1/3 or so of triple negative HER2 Positive disease, but in the two thirds of patients who have hormone receptor positive HER2 negative disease. Especially if there is negative involvement in lymph nodes or low volume involvement of the lymph nodes.”-Dr. Joseph Sparano talking about the new tool he and his team have developed
Hosted by Suzanne Stone
A proven leader in building long term community partnership opportunities, Suzanne Stone brings innovative ideas to support Komen Greater CETX’s mission in fighting breast cancer. Stone has gained experience in outreach and education, volunteer programs, donor development and fundraising over her professional career. Stone earned her Bachelor of Science degree in Radio, Television and Film from Texas Christian university and is certified in non-profit management. During her free time, she enjoys going to the beach to catch waves on her surfboard, paddle boarding and watching baseball games.
About the More Than Pink Podcast
The More Than Pink Podcast is designed to give listeners an insight on what is happening in the field of breast cancer research, treatment, screening and survivorship. Through each episode, experts in various fields share their knowledge directly with you through guided conversations on a variety of topics. If you have any questions, or comments, please email us at firstname.lastname@example.org.
Special thanks to Hologic and iHeartMedia for making this episode possible.